Permian Health Women's Lung Health Study
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age15+
SponsorPermian Health Lung Institute
About this trial
The goal of this cross-sectional observational study is to estimate the prevalence of lung function impairment as measured by spirometry in a population of Gambian women aged 15 and older. The main question\[s\] it aims to answer are:
* What is the prevalence of lung function impairment in Gambian women * What is the prevalence of eosinophilic inflammation in Gambian women
Consenting participants will undergo
* Spirometry * Fractional exhaled nitric oxide (FENO) testing * α1-antitrypsin testing in patients with lung function impairment as assessed by spirometry
Eligibility criteria
Qualifiers
Self-identified female sex
Age > 15 years: This age cutoff was chosen (as opposed to 18) because of the unique cultural norms and practices in the country where experiences and exposures occur at an earlier age than women in Western countries.
Disqualifiers
Age < 15 years
Non-resident household member
Any acutely unwell individual
Pregnancy
Trial design
Treatments tested in this trial
- Not listed
Trial groups
350 Participants
are grouped into 1 trial groupSponsors and collaborators
Permian Health Lung Institute
Lead sponsor
The Gambia Committee on Traditional Practices Affecting the Health of Women and Children (GAMCOTRAP)
Collaborator
Source ClinicalTrials.gov